Get started

Common Registration Assessment · Topic deep-dive

GPhC Skin Conditions Questions

The Board of Assessors’ June 2025 feedback singled out skin conditions as a weak area with a specific emphasis: “They are expected to know how common skin conditions present across diverse skin tones.” Most undergraduate teaching uses images and descriptions of conditions on light skin, leaving a recognised gap that the CRA is now testing.


What the GPhC actually tests on this topic

  • Recognition of eczema, psoriasis, urticaria, acne, rosacea, fungal infections, and scabies on diverse skin tones
  • Treatment selection: topical corticosteroid potency choice, antifungals, emollients
  • Counselling on use of topical corticosteroids — strength, frequency, fingertip units, areas to avoid
  • When to refer: red flags including suspected melanoma, severe drug eruptions, signs of secondary infection
  • Common dermatological adverse drug reactions and how to identify them

Common pitfalls — from the Board of Assessors’ feedback

Erythema looking different on darker skin

Erythema is harder to see on darker skin tones. It may appear violaceous, dusky, or be visible only as warmth and induration. The Board of Assessors expects you to recognise inflammatory skin signs across all skin tones — the visible cue you trained on may not apply.

Misjudging topical corticosteroid potency

Hydrocortisone 1% is mild; clobetasol propionate 0.05% is super-potent. Wrong potency is the most common topical corticosteroid prescribing error and a recurring exam pattern. Know the four potency bands and which body areas tolerate which potency.

Missing serious drug eruptions

Stevens–Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome are drug-related dermatological emergencies. Know the typical onset window after starting the offending drug and the red-flag features (mucosal involvement, fever, lymphadenopathy).


Sample practice questions

CRA-style practice questions, not real exam questions. The Board of Assessors does not endorse third-party question banks.

Skin conditions · Sample 1Medium

For an adult with type 2 diabetes who has no identified nutritional deficiency, which listed action is NOT a routine evidence-based diabetes management measure?

  1. A. Work towards regular physical activity suited to ability
  2. B. Discuss an individualised healthy eating plan
  3. C. Keep alcohol within recommended limits
  4. D. Take a daily multivitamin specifically to treat diabetes without an identified deficiency
  5. E. Review lifestyle and medication needs with the care team
Show worked answer

Correct answer: D

Physical activity, individualised healthy eating and alcohol moderation support diabetes care. A routine multivitamin does not treat type 2 diabetes when there is no deficiency or other indication.
Skin conditions · Sample 2Hard

A drug undergoes extensive first-pass metabolism when swallowed. Which listed dosage form allows absorption directly into the systemic circulation, bypassing the liver at first pass?

  1. A. Oral immediate-release tablet
  2. B. Sublingual tablet
  3. C. Topical gel applied for local effect
  4. D. Oral solution
  5. E. Modified-release oral capsule
Show worked answer

Correct answer: B

Sublingual absorption drains into the systemic venous circulation via the veins of the mouth, bypassing the liver at first pass. Every oral swallowed form passes through the gut wall and liver first.

Skin conditions — frequently asked

Why does the GPhC test skin conditions on darker skin tones?

Because most UK dermatological teaching uses imagery on light skin, leaving a recognised diagnostic gap when pharmacists assess patients with darker skin. The Board of Assessors explicitly flagged this in June 2025 feedback. The CRA tests whether you can recognise common conditions across the full range of skin tones you will see in practice.

Which resources show skin conditions on diverse skin tones?

The DFTB Skin Deep project, Mind The Gap by Black & Brown Skin, and the British Association of Dermatologists patient information leaflets show images across skin tones. The NHS website has been updated to include diverse-skin-tone imagery for common conditions. These are good supplementary references alongside the BNF.

What topical corticosteroid potency is appropriate where?

Mild (e.g. hydrocortisone 1%) for face, flexures, and infant eczema. Moderate (e.g. clobetasone butyrate 0.05%) for most adult body eczema. Potent (e.g. betamethasone valerate 0.1%) for severe eczema or short courses on resistant areas. Very potent (e.g. clobetasol propionate 0.05%) for short, specialist-supervised use only — usually palms, soles, or scalp.


Practise skin conditions questions in context

Across the full bank of GPhC exam questions — every format, with worked answers grounded in the Board of Assessors’ published feedback.

More topic deep-dives